FDA Issues Urgent Nationwide Recall for a
FDA Recalls Chantix Over Safety Concerns
The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of Chantix (varenicline)
after routine testing found elevated levels of nitrosamines,
compounds that can increase cancer risk with long-term exposure.
Why It Matters
While nitrosamines occur naturally in some foods and water,
the levels found in certain Chantix batches exceeded the FDA’s safety limits.
Regulators stressed that the move is precautionary, saying,
“the precise risk to patients is still being evaluated.”
What Happens Next
The recall, made in cooperation with the manufacturer,
aims to remove affected lots and maintain confidence in the drug supply.
Advice for Patients
Chantix has long been an effective aid to quit smoking.
Patients are advised not to panic, but to contact their healthcare providers for guidance or alternative treatments.
